Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for black patients with heart failure

被引：0
|
作者：
Tam, SW
Linde-Zwirble, WT
Worcel, M
Sabolinski, ML
Ghali, JK
Villagra, VG
Winkelmayer, WC
Angus, DC
机构：
[1] ZD Associates, Perkasie, PA USA
[2] NitroMed Inc, Lexington, MA USA
[3] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA USA
[4] Hlth & Technol Vector Inc, Farmington, CT USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3031
引用
收藏
页码：U705 / U705
页数：1
相关论文
共 50 条
  • [21] Fixed-dose combination of isosorbide dinitrate and hydralazine improves quality of life in African Americans with heart failure: Results from African-American heart failure trial
    Carson, P
    Ghali, JK
    Tam, SW
    Worcel, M
    CIRCULATION, 2005, 112 (17) : U705 - U705
  • [22] Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American heart failure trial)
    Yancy, Clyde W.
    Ghali, Jalal K.
    Braman, Virginia M.
    Sabolinski, Michael L.
    Worcel, Manuel
    Archambault, W. Tad
    Franciosa, Joseph A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (04): : 684 - 689
  • [23] The benefits of the fixed-dose combination of isosorbide dinitrate and hydralazine in A-HeFT are not influenced by the absence or presence of diabetes
    Miller, Alan
    Yancy, Clyde W.
    Sabofinski, Michael L.
    Braman, Virginia M.
    Worcel, Manuel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 44A - 44A
  • [24] Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure
    Flack, John M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (03) : 275 - 277
  • [25] Lack of Bioequivalence between Different Formulations of Isosorbide Dinitrate and Hydralazine and the Fixed-Dose Combination of Isosorbide Dinitrate/HydralazineThe V-HeFT Paradox
    S. William Tam
    Michael L. Sabolinski
    Manuel Worcel
    Milton Packer
    Jay N. Cohn
    Clinical Pharmacokinetics, 2007, 46 : 885 - 895
  • [26] Effects of Fixed-Dose Isosorbide Dinitrate/Hydralazine on Diastolic Function and Exercise Capacity in Hypertension-Induced Diastolic Heart Failure
    Wilson, Richard M.
    De Silva, Deepa S.
    Sato, Kaori
    Izumiya, Yasuhiro
    Sam, Flora
    HYPERTENSION, 2009, 54 (03) : 583 - U265
  • [27] BUDGET IMPACT ANALYSIS OF FIXED-DOSE ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE IN TREATMENT OF HEART FAILURE FROM A US MEDICARE POPULATION
    Keum, J.
    Peasah, S. K.
    VALUE IN HEALTH, 2019, 22 : S125 - S125
  • [28] Effectiveness of Hydralazine/Isosorbide Dinitrate in Racial/Ethnic Subgroups With Heart Failure
    Hammermeister, Karl E.
    Fairclough, Diane
    Emsermann, Caroline Bublitz
    Hamman, Richard
    Ho, Michael
    Phibbs, Stephanie
    Plomondon, Mary
    Valuck, Robert
    West, David
    Steiner, John F.
    CLINICAL THERAPEUTICS, 2009, 31 (03) : 632 - 643
  • [29] Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: Results from A-HeFT
    Cohn, Jay N.
    Tam, William
    Anand, Inder S.
    Taylor, Anne L.
    Sabolfnski, Michael L.
    Worcel, Manuel
    JOURNAL OF CARDIAC FAILURE, 2007, 13 (05) : 331 - 339
  • [30] Effect of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine on All Hospitalizations and on 30-Day Readmission Rates in Patients With Heart Failure Results From the African-American Heart Failure Trial
    Anand, Inder S.
    Win, Sithu
    Rector, Thomas S.
    Cohn, Jay N.
    Taylor, Anne L.
    CIRCULATION-HEART FAILURE, 2014, 7 (05) : 759 - U136
12345